Hyderabad-based Mold-Tek Packaging is witnessing strong growth in its pharmaceutical packaging segment, with ambitious targets of INR 30–35 crore in revenue for FY26 and INR 50–60 crore by FY27.

Speaking to a news channel, Chairman and Managing Director Janumahanti Lakshmana Rao said the pharma business is gaining momentum as more clients are coming on board.

Regarding the pharma segment, he said, “The numbers are increasing rapidly because we are adding on new clients. Several clients are testing our products for machine suitability and stability of their products and one by one they are clearing those products.”

In the first quarter of FY26 (April–June 2025), the company secured 3–4 new pharmaceutical clients, who are either releasing commercial orders or testing our products online.

According to Rao, a few more clients have expressed willingness to start testing the company’s products in an experimental way.

Rao confirmed that commercial orders have already been received from two well-known pharma companies, with supply scheduled to begin by July or August.

To support the rising demand, Mold-Tek is ramping up investments in both its pharma and fast-moving consumer goods (FMCG) verticals.

The company is enhancing its packaging capacities by procuring new machines and moulds and has recently acquired 2.5 hectares of land in Telangana for future expansion, which includes a new line of ophthalmic containers with innovative designs tailored to attract pharmaceutical clients.

Last year, the company commissioned three manufacturing units—located in Panipat (Haryana), Cheyyar (Tamil Nadu), and Sultanpur (Telangana)—with a combined investment exceeding INR 100 crore.

These facilities were projected to add around 5,500 tonnes to Mold-Tek’s overall production capacity. Additionally, a 1,500 tonne manufacturing plant was set up in Mahad, Maharashtra with an investment of ?20 crore, to bolster pharma packaging operations.

Together, these four new units were projected to raise the company’s total production capacity to 54,000 tonnes by FY25, significantly strengthening its position in the pharma, food, and FMCG packaging markets.

Over the next 5–6 years, the company expects these segments to contribute nearly 50 percent of its overall turnover.

Looking ahead to FY26, Mold-Tek is targeting 12–15 percent volume growth, with expectations of sustaining this momentum into FY27.